?
Eastern Mediterranean Health Genomics and Biotechnology Network (EMHGBN) was created in 2004 for representatives of selected centres of excellence in (health related) Molecular biology, Biotechnology & genomics in the Eastern Mediterranean Region by recommendation of WHO/EMRO efforts..
Responsibility for hosting the network secretariat should rest with Member States. The Secretariat should rotate among the Member States after a defined period of?? time. Membership should be open to all interested partners in Member States.
|
|
- To create and sustain value by being recognized as a player in the international biopharmaceutical, genomics and biotechnological industry aiming at promoting health in the region.
- Sustainable development of health genomics and biotechnology through facilitation of high quality R&D training and sharing information, experience distribution and technology transfer in order to meet common and regional health needs of member countries. |
- To induce collaboration in production, training, Research & Development to be self reliant in biotechnology and industries.
- To facilitate cooperation between wealthy and poor countries to upgrade health standards. |
Written by EMGEN
|
Monday, 15 September 2008 11:23 |
- To promote regional common health objectives through R&D partnership and collaboration. - To facilitate capacity building in genomics and biotechnology through public awareness and promotion, training and educational programs. - To prioritize health related R&D in genomics and biotechnology - To support production of specific and new products - To meet internationally recognized standards in health genomics and biotechnology
|
Last Updated on Tuesday, 16 July 2013 05:06 |
Written by EMGEN
|
Monday, 26 January 2009 05:14 |
Download Strategic Plan |
Last Updated on Wednesday, 24 July 2013 08:17 |
|
|
|
|